Cardiac surgery, a specialized branch of medical intervention, focuses on the surgical treatment of heart diseases and disorders. This intricate field encompasses a range of procedures designed to address various cardiac conditions, including coronary artery disease, heart valve defects, congenital heart abnormalities, and heart failure. Cardiac surgeons are highly skilled professionals who perform intricate surgeries such as coronary artery bypass grafting, valve replacement or repair, and heart transplantations. These procedures aim to restore or improve the heart's functionality, ensuring optimal blood circulation throughout the body. Advancements in technology and surgical techniques have significantly enhanced the success rates and safety of cardiac surgeries, allowing patients to benefit from improved quality of life and extended lifespans. The collaboration between cardiac surgeons, cardiologists, and other healthcare professionals plays a crucial role in providing comprehensive care for individuals with complex heart issues, emphasizing the importance of a multidisciplinary approach in the realm of cardiac health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India